[M. tuberculosis drug resistance and occurrence in patients with pulmonary tuberculosis].
D010131:Aminosalicylic Acid / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D006801:Humans; D015994:Incidence; D007612:Kanamycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012189:Retrospective Studies; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D014455:Ukraine / Q000453:epidemiology
D000995:Antitubercular Agents; D007612:Kanamycin; D010131:Aminosalicylic Acid; D012293:Rifampin; D013307:Streptomycin
Poshyrenist' ta spektr medykamentoznoï stiĭkosti M. tuberculosis u khvorykh na tyberkul'oz lehen'.